1cP-LSD
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C24H29N3O2 |
| Molar mass | 391.515 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug.[1] In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.[2]
Legal status
Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December 2019.[3]
See also
References
- ^ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R. "[Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet]". Yakugaku Zasshi. 140 (11): 1405–1413. doi:10.1248/yakushi.20-00124. PMID 33132277.
- ^ Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, et al. (June 2020). "Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)". Drug Testing and Analysis. 12 (6): 812–826. doi:10.1002/dta.2789. PMID 32180350.
- ^ "Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara" [Twenty-three substances are proposed to be classified as drugs or dangerous goods] (in Swedish). Folkhälsomyndigheten. December 18, 2019.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |